The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

If you’re struggling with depression, the most important question about taking an antidepressant is whether it will work. But ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...

The NHS specifically warns patients taking selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline ...

A 48-year-old woman has claimed antidepressants left her bedridden, suicidal and reliant on her parents to cater for her every waking need. Lingling Wang, a banking consultant from Surrey ...

A woman who said she has become severely suicidal during a year of being prescribed the same antidepressants as royal family ...

The selective serotonin reuptake inhibitor sertraline is often among the preferred antidepressants to take when breastfeeding ...